Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition

Objective To assess the bioequivalence of single dose trazodone hydrochloride USP 100 mg tablets administered as an oral dose under fed condition. Methods This study was an open-label, balanced, randomized, two-sequence, two-treatment, two-period, single oral dose, crossover bioequivalence study in...

Full description

Bibliographic Details
Main Authors: PRASHANT eKALE, Yadvendra eAgrawal
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00224/full
_version_ 1818435560184741888
author PRASHANT eKALE
PRASHANT eKALE
Yadvendra eAgrawal
author_facet PRASHANT eKALE
PRASHANT eKALE
Yadvendra eAgrawal
author_sort PRASHANT eKALE
collection DOAJ
description Objective To assess the bioequivalence of single dose trazodone hydrochloride USP 100 mg tablets administered as an oral dose under fed condition. Methods This study was an open-label, balanced, randomized, two-sequence, two-treatment, two-period, single oral dose, crossover bioequivalence study in healthy, adult, human subjects under fed conditions. After an overnight fast of at least 10 hours, the subjects were served a high fat and high calorie vegetarian breakfast, which they were required to consume within 30 minutes. A single oral dose (100 mg) of either the test or the reference product was administered to the subjects. The primary pharmacokinetic parameters, maximum plasma concentration (Cmax) and area under the plasma concentration–time curve (AUC) from time zero to last measurable concentration (AUC0-t) and extrapolated to infinity (AUC0-) were compared by an analysis of variance using log-transformed data. Bioequivalence was concluded if the 90% confidence intervals (CIs) of the adjusted geometric mean (gMean) ratios for Cmax and AUC were within the predetermined range of 80%-125%, in accordance with regulatory requirements. Results For the test formulation, the trazodone gMean Cmax was 1480.9 ng/mL (vs. 1520.2 ng/mL for reference), AUC0-t was 18193.0 ng·h/mL (vs. 18209.8 ng·h/mL) and AUC0- was 19346.3 ng·h/mL (vs. 19393.4 ng·h/mL). The 90% CIs for the ratio (test/reference) were 93.0-102.0% for Cmax, 96.7-103.2% for AUC0-t and 96.1-103.5% for AUC0-. There were no deaths or serious adverse events during the conduct of the study. Conclusion Test product when compared with the Reference product meets the bioequivalence criteria with respect to the rate and extent of absorption of Trazodone under fed condition.
first_indexed 2024-12-14T16:54:49Z
format Article
id doaj.art-9a5030430c5a4f0781a9c076a3a08fd9
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-14T16:54:49Z
publishDate 2015-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-9a5030430c5a4f0781a9c076a3a08fd92022-12-21T22:53:59ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122015-10-01610.3389/fphar.2015.00224147145Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed conditionPRASHANT eKALE0PRASHANT eKALE1Yadvendra eAgrawal2Lambda Therapeutic Research LimitedGujarat Forensic Sciences UniversityGujarat Forensic Sciences UniversityObjective To assess the bioequivalence of single dose trazodone hydrochloride USP 100 mg tablets administered as an oral dose under fed condition. Methods This study was an open-label, balanced, randomized, two-sequence, two-treatment, two-period, single oral dose, crossover bioequivalence study in healthy, adult, human subjects under fed conditions. After an overnight fast of at least 10 hours, the subjects were served a high fat and high calorie vegetarian breakfast, which they were required to consume within 30 minutes. A single oral dose (100 mg) of either the test or the reference product was administered to the subjects. The primary pharmacokinetic parameters, maximum plasma concentration (Cmax) and area under the plasma concentration–time curve (AUC) from time zero to last measurable concentration (AUC0-t) and extrapolated to infinity (AUC0-) were compared by an analysis of variance using log-transformed data. Bioequivalence was concluded if the 90% confidence intervals (CIs) of the adjusted geometric mean (gMean) ratios for Cmax and AUC were within the predetermined range of 80%-125%, in accordance with regulatory requirements. Results For the test formulation, the trazodone gMean Cmax was 1480.9 ng/mL (vs. 1520.2 ng/mL for reference), AUC0-t was 18193.0 ng·h/mL (vs. 18209.8 ng·h/mL) and AUC0- was 19346.3 ng·h/mL (vs. 19393.4 ng·h/mL). The 90% CIs for the ratio (test/reference) were 93.0-102.0% for Cmax, 96.7-103.2% for AUC0-t and 96.1-103.5% for AUC0-. There were no deaths or serious adverse events during the conduct of the study. Conclusion Test product when compared with the Reference product meets the bioequivalence criteria with respect to the rate and extent of absorption of Trazodone under fed condition.http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00224/fullTrazodonepharmacokineticsLC-MS/MSClinical TrialBioequivalence
spellingShingle PRASHANT eKALE
PRASHANT eKALE
Yadvendra eAgrawal
Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
Frontiers in Pharmacology
Trazodone
pharmacokinetics
LC-MS/MS
Clinical Trial
Bioequivalence
title Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
title_full Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
title_fullStr Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
title_full_unstemmed Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
title_short Pharmacokinetics of single oral dose trazodone : a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
title_sort pharmacokinetics of single oral dose trazodone a randomized two period cross over trial in healthy adult human volunteers under fed condition
topic Trazodone
pharmacokinetics
LC-MS/MS
Clinical Trial
Bioequivalence
url http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00224/full
work_keys_str_mv AT prashantekale pharmacokineticsofsingleoraldosetrazodonearandomizedtwoperiodcrossovertrialinhealthyadulthumanvolunteersunderfedcondition
AT prashantekale pharmacokineticsofsingleoraldosetrazodonearandomizedtwoperiodcrossovertrialinhealthyadulthumanvolunteersunderfedcondition
AT yadvendraeagrawal pharmacokineticsofsingleoraldosetrazodonearandomizedtwoperiodcrossovertrialinhealthyadulthumanvolunteersunderfedcondition